MedPath

Effects of Oral Care on Outcomes in Admitted Patients with Heart Failure

Not Applicable
Recruiting
Conditions
Heart Failure
Registration Number
JPRN-UMIN000049148
Lead Sponsor
Tokyo Medical University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
80
Inclusion Criteria

Not provided

Exclusion Criteria

1. Patients with severe renal dysfunction (eGFR under 30 mL/min/1.73 m2), patients on maintenance dialysis, patients with known bilateral renal artery stenosis (known renal artery stenosis in the remaining kidney in patients with one kidney) 2. Patients with severe hepatic dysfunction (Child-Pugh classification C) 3. Patients with cardiogenic shock 4. Patients on cardiopulmonary assist devices, left ventricular assist ventricular assist devices, or ventilators 5. Patients with acute coronary syndrome or stroke within 30 days prior to randomization 6. Patients with a history of surgical or percutaneous treatment for cardiovascular disease within 30 days of randomization. 7. Patients with a preplanned coronary reconstruction or surgical or percutaneous treatment for cardiovascular disease during the individual observation period. 8. Patients with a preplanned treatment such as electrical cardioversion, cardiac resynchronization therapy or pacemaker implantation during the individual observation period. 9. Patients with obstructive hypertrophic cardiomyopathy or a history of or concomitant infiltrative cardiomyopathy such as amyloidosis or sarcoidosis 10. Patients with active pericardial disease 11. Patients with a history of dental visits to other hospitals within 3 months or currently undergoing dental treatment for dental caries, etc. 12. Patients with a history of or on the waiting list for a heart transplant 13. Patients with active infectious diseases or serious chronic respiratory diseases 14. Pregnant, potentially pregnant, or lactating patients 15. Other patients deemed inappropriate for this study by the principal investigator or subinvestigators (e.g., patients with active malignancies)

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath